As Aβ42 level is reduced in the serum of patients with AD (Lui et al., 2010), activation of monocytes by Aβ42 is decreased followed by reduction in the secretion of ANXA1 from monocytes in the blood. The gene discussed is ANXA1; the disease is Alzheimer disease.